Free Trial

Replimune Group (REPL) News Today

Replimune Group logo
$9.05 -0.01 (-0.11%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$9.06 +0.00 (+0.06%)
As of 04/25/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Replimune Group, Inc. stock logo
Renaissance Technologies LLC Buys 49,200 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Renaissance Technologies LLC lifted its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 45.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 156,936 shares of the company's stock after purchasing an additional 49,200 shares during the p
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Trading Down 2.9% - Should You Sell?
Replimune Group (NASDAQ:REPL) Shares Down 2.9% - Time to Sell?
Replimune Group, Inc. stock logo
Diadema Partners LP Purchases Shares of 114,000 Replimune Group, Inc. (NASDAQ:REPL)
Diadema Partners LP acquired a new position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 114,000 shares of the company's stock, valued at appr
Replimune Group, Inc. stock logo
Marshall Wace LLP Takes $10.85 Million Position in Replimune Group, Inc. (NASDAQ:REPL)
Marshall Wace LLP acquired a new position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 896,184 shares of the compan
Replimune Group, Inc. stock logo
Jump Financial LLC Has $865,000 Position in Replimune Group, Inc. (NASDAQ:REPL)
Jump Financial LLC grew its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 95.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,443 shares of the company's stock afte
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Stock Price Up 6.7% - Time to Buy?
Replimune Group (NASDAQ:REPL) Shares Up 6.7% - Here's Why
Replimune Group, Inc. stock logo
Replimune Group, Inc. (NASDAQ:REPL) Position Boosted by Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd boosted its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 11.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 321,746 shares of the company's stock after bu
Replimune Group, Inc. stock logo
JPMorgan Chase & Co. Has $5.89 Million Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL)
JPMorgan Chase & Co. lifted its holdings in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 95.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 486,609 shares of the company's stock after buying an additional 237,26
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Trading 4.4% Higher - Here's Why
Replimune Group (NASDAQ:REPL) Trading Up 4.4% - Here's What Happened
Replimune Group, Inc. stock logo
Alliancebernstein L.P. Sells 48,397 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Alliancebernstein L.P. trimmed its position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 9.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 440,612 shares of the company's stock after selling 48,39
Replimune Group, Inc. stock logo
Vanguard Group Inc. Has $43.55 Million Holdings in Replimune Group, Inc. (NASDAQ:REPL)
Vanguard Group Inc. lifted its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,595,848 shares of the company's stock after buying an ad
Replimune Group, Inc. stock logo
Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of "Buy" from Analysts
Shares of Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) have been given an average recommendation of "Buy" by the eight ratings firms that are covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has given a strong buy rec
Replimune Group, Inc. stock logo
Wellington Management Group LLP Raises Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL)
Wellington Management Group LLP raised its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 352.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,096,744 shares of the
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Shares Down 7.1% - Time to Sell?
Replimune Group (NASDAQ:REPL) Stock Price Down 7.1% - What's Next?
Replimune Group Inc.
Replimune Group, Inc. stock logo
Trexquant Investment LP Sells 71,879 Shares of Replimune Group, Inc. (NASDAQ:REPL)
Trexquant Investment LP trimmed its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 27.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 194,592 shares of the company's stock after selling 71,879 shares du
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Stock Price Up 6.4% - What's Next?
Replimune Group (NASDAQ:REPL) Shares Up 6.4% - What's Next?
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Trading Down 7.6% - What's Next?
Replimune Group (NASDAQ:REPL) Stock Price Down 7.6% - Should You Sell?
Replimune Group, Inc. stock logo
611,013 Shares in Replimune Group, Inc. (NASDAQ:REPL) Purchased by Artisan Partners Limited Partnership
Artisan Partners Limited Partnership acquired a new position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 611,013 shares of the
Replimune Group, Inc. stock logo
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Swiss National Bank
Swiss National Bank increased its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 57.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 103,700 shares of the company'
Replimune Group, Inc. stock logo
Charles Schwab Investment Management Inc. Has $6.16 Million Stake in Replimune Group, Inc. (NASDAQ:REPL)
Charles Schwab Investment Management Inc. raised its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 508,398 shares of the company's stoc
Replimune Group, Inc. stock logo
Rosalind Advisors Inc. Purchases New Position in Replimune Group, Inc. (NASDAQ:REPL)
Rosalind Advisors Inc. acquired a new position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 260,000 shares of the company
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Shares Down 5.6% - What's Next?
Replimune Group (NASDAQ:REPL) Trading Down 5.6% - Here's What Happened
Replimune Group, Inc. stock logo
Victory Capital Management Inc. Purchases Shares of 44,880 Replimune Group, Inc. (NASDAQ:REPL)
Victory Capital Management Inc. purchased a new stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 44,880 shares of the company's stock, valued at approxi
Replimune Group, Inc. stock logo
Replimune Group, Inc. (NASDAQ:REPL) Given Average Recommendation of "Buy" by Brokerages
Shares of Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) have been assigned an average rating of "Buy" from the eight analysts that are covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating on th
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Shares Up 6.4% - Still a Buy?
Replimune Group (NASDAQ:REPL) Stock Price Up 6.4% - Here's Why
Replimune Group, Inc. stock logo
New York State Common Retirement Fund Purchases 31,231 Shares of Replimune Group, Inc. (NASDAQ:REPL)
New York State Common Retirement Fund raised its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 260.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 43,204 shares of the company's stock afte
Replimune Group, Inc. stock logo
Los Angeles Capital Management LLC Lowers Position in Replimune Group, Inc. (NASDAQ:REPL)
Los Angeles Capital Management LLC lowered its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 41.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 34,547 shares of the company's
Replimune Group, Inc. stock logo
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Replimune Group (NASDAQ:REPL) Stock
JPMorgan Chase & Co. lifted their price objective on shares of Replimune Group from $16.00 to $18.00 and gave the stock an "overweight" rating in a research report on Wednesday.
Replimune price target raised to $18 from $16 at JPMorgan
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Shares Up 6.1% - Still a Buy?
Replimune Group (NASDAQ:REPL) Shares Up 6.1% - Here's What Happened
Replimune Group, Inc. stock logo
Replimune Group, Inc. (NASDAQ:REPL) Receives Average Recommendation of "Buy" from Brokerages
Shares of Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) have been given a consensus recommendation of "Buy" by the eight brokerages that are covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation and one has assigned a strong buy rec
Replimune Group, Inc. stock logo
Leerink Partnrs Predicts Weaker Earnings for Replimune Group
Replimune Group, Inc. (NASDAQ:REPL - Free Report) - Analysts at Leerink Partnrs decreased their FY2025 earnings estimates for shares of Replimune Group in a research note issued on Wednesday, February 12th. Leerink Partnrs analyst J. Chang now forecasts that the company will post earnings of ($2.
Replimune Group, Inc. stock logo
FY2025 EPS Estimates for Replimune Group Lowered by Wedbush
Replimune Group, Inc. (NASDAQ:REPL - Free Report) - Analysts at Wedbush cut their FY2025 earnings per share estimates for Replimune Group in a note issued to investors on Wednesday, February 12th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($3.07) per share
Replimune Group, Inc. stock logo
Replimune Group, Inc. (NASDAQ:REPL) Short Interest Up 16.7% in January
Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 8,470,000 shares, a growth of 16.7% from the January 15th total of 7,260,000 shares. Based on an average daily trading volume, of 885,200 shares, the short-interest ratio is presently 9.6 days.
Replimune price target raised to $22 from $21 at H.C. Wainwright
Barclays Keeps Their Buy Rating on Replimune Group (REPL)
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Price Target Raised to $22.00
HC Wainwright boosted their target price on shares of Replimune Group from $21.00 to $22.00 and gave the stock a "buy" rating in a report on Thursday.
Replimune price target raised to $19 from $16 at Wedbush
Replimune price target raised to $21 from $18 at Leerink
Replimune: A Misunderstood Contender In Oncolytics
Replimune reports Q3 EPS (79c) vs (77c) last year
Replimune Group, Inc. stock logo
Replimune Group (NASDAQ:REPL) Announces Earnings Results
Replimune Group (NASDAQ:REPL - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.79) EPS for the quarter, missing analysts' consensus estimates of ($0.70) by ($0.09).
Replimune Group, Inc. stock logo
Replimune Group (REPL) Expected to Announce Earnings on Thursday
Replimune Group (NASDAQ:REPL) will be releasing earnings before the market opens on Thursday, February 13.
Get Replimune Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for REPL and its competitors with MarketBeat's FREE daily newsletter.

REPL Media Mentions By Week

REPL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

REPL
News Sentiment

1.51

0.86

Average
Medical
News Sentiment

REPL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

REPL Articles
This Week

7

4

REPL Articles
Average Week

Get Replimune Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for REPL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:REPL) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners